Summary
Guardant Health, Inc. (GH) filed an 8-K on October 29, 2025, primarily to report its financial results for the fiscal quarter ended September 30, 2025. The key details of these results are available in the press release furnished as Exhibit 99.1. Investors should review this press release for specific revenue figures, profitability metrics, and any forward-looking guidance provided by the company. While this 8-K itself doesn't contain detailed financial tables, it serves as the official notification that the company has disseminated its quarterly performance update.
Key Highlights
- 1Guardant Health announced its third-quarter financial results for the period ending September 30, 2025.
- 2The press release containing the detailed financial results is furnished as Exhibit 99.1 to the 8-K filing.
- 3Investors should consult the furnished press release for specific performance metrics, revenue, and earnings per share.
- 4The filing incorporates the press release by reference, making its contents directly relevant to the company's reported performance.
- 5This report is an update on the company's operational and financial condition for the specified quarter.
- 6The information furnished is not considered 'filed' for Section 18 purposes but is crucial for understanding recent company performance.
Frequently Asked Questions
The primary purpose of this 8-K filing is to report Guardant Health's financial results for the fiscal quarter ended September 30, 2025. The detailed information is provided in a press release furnished with the filing.
The specific financial results, including revenue, earnings, and any updated guidance, are detailed in the press release included as Exhibit 99.1 to this 8-K filing.
No, this 8-K filing primarily references a press release (Exhibit 99.1) which contains the detailed financial results. The 8-K itself serves as the notification that these results have been released.
This means that the company is not subject to the same liability under Section 18 of the Securities Exchange Act of 1934 for this specific information as it would be if it were formally 'filed'. However, the information is still crucial for investors to understand the company's performance.